Key indicatorsSingle-crystal X-ray study T = 173 K Mean (C-C) = 0.004 Å R factor = 0.078 wR factor = 0.199 Data-to-parameter ratio = 17.7For details of how these key indicators were automatically derived from the article, see
Key indicatorsSingle-crystal X-ray study T = 173 K Mean (C-C) = 0.005 Å R factor = 0.033 wR factor = 0.075 Data-to-parameter ratio = 6.9For details of how these key indicators were automatically derived from the article, seePerspective view of the cation of (I), with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. organic papers Acta Cryst. (2006). E62, o372-o373 Schö del et al. C 16 H 36 N + ÁC 24 BF 20 À o373 Figure 2Perspective view of the anion of (I), with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level.
The molecule of the title compound, C48H60N4O12, is located on a crystallographic twofold rotation axis. It is found in the typical pinched cone conformation. The dihedral angles between the reference plane (defined by the C atoms of the methylene bridges) and the benzene rings are 83.33 (6) and 141.61 (5)°.
The title compound, C9H25N32+·2PF6−, consists of discrete hexafluorophosphate anions and 1,1,4,7,7‐pentamethyldiethylenetriamine cations. The geometric parameters are in the usual ranges. Only one PF6− cation forms hydrogen bonds with both NH donors of the cation.
The title compound, [Cu2(C2H3O2)2(C26H24P2)3]·2C4H10O, crystallizes with one dicopper(I) unit located on a centre of inversion and two diethyl ether molecules in general positions. The Cu atoms exhibit slightly distorted tetrahedral coordination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.